1. Home
  2. PTGX vs ALSN Comparison

PTGX vs ALSN Comparison

Compare PTGX & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$138.00

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Logo Allison Transmission Holdings Inc.

ALSN

Allison Transmission Holdings Inc.

HOLD

Current Price

$124.29

Market Cap

9.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTGX
ALSN
Founded
2006
1915
Country
United States
United States
Employees
N/A
4000
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
9.5B
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
PTGX
ALSN
Price
$138.00
$124.29
Analyst Decision
Strong Buy
Hold
Analyst Count
13
7
Target Price
$108.23
$117.57
AVG Volume (30 Days)
593.6K
836.9K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
0.84%
EPS Growth
N/A
N/A
EPS
0.05
1.33
Revenue
N/A
$3,010,000,000.00
Revenue This Year
$874.25
$94.98
Revenue Next Year
N/A
$5.30
P/E Ratio
$2,645.60
$87.45
Revenue Growth
N/A
N/A
52 Week Low
$50.49
$76.01
52 Week High
$143.29
$137.62

Technical Indicators

Market Signals
Indicator
PTGX
ALSN
Relative Strength Index (RSI) N/A 48.92
Support Level N/A $112.48
Resistance Level N/A $118.64
Average True Range (ATR) 0.00 3.37
MACD 0.00 -0.12
Stochastic Oscillator 0.00 38.34

Price Performance

Historical Comparison
PTGX
ALSN

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.

Share on Social Networks: